These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 16768292)

  • 1. Fabrication and characterization of poly(DL-lactic-co-glycolic acid)/zirconia-hybridized amorphous calcium phosphate composites.
    Whited BM; Goldstein AS; Skrtic D; Love BJ
    J Biomater Sci Polym Ed; 2006; 17(4):403-18. PubMed ID: 16768292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fabrication and characterization of poly(lactic-co-glycolic acid) microsphere/amorphous calcium phosphate scaffolds.
    Popp JR; Laflin KE; Love BJ; Goldstein AS
    J Tissue Eng Regen Med; 2012 Jan; 6(1):12-20. PubMed ID: 21312335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Porous poly(DL-lactic-co-glycolic acid)/calcium phosphate cement composite for reconstruction of bone defects.
    Ruhé PQ; Hedberg-Dirk EL; Padron NT; Spauwen PH; Jansen JA; Mikos AG
    Tissue Eng; 2006 Apr; 12(4):789-800. PubMed ID: 16674292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro evaluation of osteoblastic differentiation on amorphous calcium phosphate-decorated poly(lactic-co-glycolic acid) scaffolds.
    Popp JR; Laflin KE; Love BJ; Goldstein AS
    J Tissue Eng Regen Med; 2011 Nov; 5(10):780-9. PubMed ID: 22002921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly(alpha-hydroxyl acids)/hydroxyapatite porous composites for bone-tissue engineering. I. Preparation and morphology.
    Zhang R; Ma PX
    J Biomed Mater Res; 1999 Mar; 44(4):446-55. PubMed ID: 10397949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel porous hydroxyapatite prepared by combining H2O2 foaming with PU sponge and modified with PLGA and bioactive glass.
    Huang X; Miao X
    J Biomater Appl; 2007 Apr; 21(4):351-74. PubMed ID: 16543281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of bioactive glass content on synthesis and bioactivity of composite poly (lactic-co-glycolic acid)/bioactive glass substrate for tissue engineering.
    Yao J; Radin S; S Leboy P; Ducheyne P
    Biomaterials; 2005 May; 26(14):1935-43. PubMed ID: 15576167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone augmentation using a highly porous PLGA/β-TCP scaffold containing fibroblast growth factor-2.
    Yoshida T; Miyaji H; Otani K; Inoue K; Nakane K; Nishimura H; Ibara A; Shimada A; Ogawa K; Nishida E; Sugaya T; Sun L; Fugetsu B; Kawanami M
    J Periodontal Res; 2015 Apr; 50(2):265-73. PubMed ID: 24966062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoblast response to zirconia-hybridized pyrophosphate-stabilized amorphous calcium phosphate.
    Whited BM; Skrtic D; Love BJ; Goldstein AS
    J Biomed Mater Res A; 2006 Mar; 76(3):596-604. PubMed ID: 16278876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and degradation characteristics of an innovative porous PLGA/TCP scaffold incorporated with bioactive molecular icaritin.
    Xie XH; Wang XL; Zhang G; He YX; Wang XH; Liu Z; He K; Peng J; Leng Y; Qin L
    Biomed Mater; 2010 Oct; 5(5):054109. PubMed ID: 20876954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surface modification of biodegradable polymer/TCP scaffolds and related research].
    Ma X; Hu Y; Wu X; Yan Y; Xiong Z; Lu R; Wang J; Li D; Xu X
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Jun; 25(3):571-7. PubMed ID: 18693433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a 95/5 poly(L-lactide-co-glycolide)/hydroxylapatite and beta-tricalcium phosphate scaffold as bone replacement material via selective laser sintering.
    Simpson RL; Wiria FE; Amis AA; Chua CK; Leong KF; Hansen UN; Chandrasekaran M; Lee MW
    J Biomed Mater Res B Appl Biomater; 2008 Jan; 84(1):17-25. PubMed ID: 17465027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of pore size and structure of tissue engineering scaffolds produced by supercritical fluid processing.
    Tai H; Mather ML; Howard D; Wang W; White LJ; Crowe JA; Morgan SP; Chandra A; Williams DJ; Howdle SM; Shakesheff KM
    Eur Cell Mater; 2007 Dec; 14():64-77. PubMed ID: 18085505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of anabolic and catabolic responses via a porous polymer scaffold manufactured using thermally induced phase separation.
    Yu NY; Schindeler A; Peacock L; Mikulec K; Fitzpatrick J; Ruys AJ; Cooper-White JJ; Little DG
    Eur Cell Mater; 2013 Feb; 25():190-203. PubMed ID: 23444237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biocompatibility and bone-repairing effects: comparison between porous poly-lactic-co-glycolic acid and nano-hydroxyapatite/poly(lactic acid) scaffolds.
    Zong C; Qian X; Tang Z; Hu Q; Chen J; Gao C; Tang R; Tong X; Wang J
    J Biomed Nanotechnol; 2014 Jun; 10(6):1091-104. PubMed ID: 24749403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and property of a novel bone graft composite consisting of rhBMP-2 loaded PLGA microspheres and calcium phosphate cement.
    Fei Z; Hu Y; Wu D; Wu H; Lu R; Bai J; Song H
    J Mater Sci Mater Med; 2008 Mar; 19(3):1109-16. PubMed ID: 17701313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biofabrication of a PLGA-TCP-based porous bioactive bone substitute with sustained release of icaritin.
    Xie XH; Wang XL; Zhang G; He YX; Leng Y; Tang TT; Pan X; Qin L
    J Tissue Eng Regen Med; 2015 Aug; 9(8):961-72. PubMed ID: 23255530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Porous polymer/hydroxyapatite scaffolds: characterization and biocompatibility investigations.
    Douglas T; Pamula E; Hauk D; Wiltfang J; Sivananthan S; Sherry E; Warnke PH
    J Mater Sci Mater Med; 2009 Sep; 20(9):1909-15. PubMed ID: 19415229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved biocompatibility of poly(lactic-co-glycolic acid) orv and poly-L-lactic acid blended with nanoparticulate amorphous calcium phosphate in vascular stent applications.
    Zheng X; Wang Y; Lan Z; Lyu Y; Feng G; Zhang Y; Tagusari S; Kislauskis E; Robich MP; McCarthy S; Sellke FW; Laham R; Jiang X; Gu WW; Wu T
    J Biomed Nanotechnol; 2014 Jun; 10(6):900-10. PubMed ID: 24749387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanosized mesoporous bioactive glass/poly(lactic-co-glycolic acid) composite-coated CaSiO3 scaffolds with multifunctional properties for bone tissue engineering.
    Shi M; Zhai D; Zhao L; Wu C; Chang J
    Biomed Res Int; 2014; 2014():323046. PubMed ID: 24724080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.